The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas. (Record no. 24543293)

MARC details
000 -LEADER
fixed length control field 01589 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517012835.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201511s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1473-4877
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1185/03007995.2015.1008131
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Macalalad, Alexander R
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20151106
245 00 - TITLE STATEMENT
Title The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Current medical research and opinion
Date of publication, distribution, etc. Mar 2015
300 ## - PHYSICAL DESCRIPTION
Extent 537-45 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Age Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brentuximab Vedotin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Management
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Progression
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hodgkin Disease
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoconjugates
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ki-1 Antigen
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Large-Cell, Anaplastic
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Targeted Therapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recurrence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sex Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McAuliffe, Megan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yang, Hongbo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kageleiry, Andrew
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhong, Yichen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wu, Eric Q
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shonukan, Oluwatoyin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bonthapally, Vijayveer
773 0# - HOST ITEM ENTRY
Title Current medical research and opinion
Related parts vol. 31
-- no. 3
-- p. 537-45
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1185/03007995.2015.1008131">https://doi.org/10.1185/03007995.2015.1008131</a>
Public note Available from publisher's website

No items available.